Corticosteroid therapy for critically ill patients with middle east respiratory syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 197, Issue 6, 2018, Pages 757-767

  Arabi, Yaseen M ^a   Mandourah, Yasser ^b   Al Hameed, Fahad ^c   Sindi, Anees A ^d   Almekhlafi, Ghaleb A ^b   Hussein, Mohamed A ^e   Jose, Jesna ^e   Pinto, Ruxandra ^f   Al Omari, Awad ^g,h   Kharaba, Ayman ^i,j   Almotairi, Abdullah ^k   Al Khatib, Kasim ^l   Alraddadi, Basem ^g,m   Shalhoub, Sarah ⁿ   Abdulmomen, Ahmed ^o   Qushmaq, Ismael ^m   Mady, Ahmed ^p,q   Mady, Othman ^m   Al Aithan, Abdulsalam M ^r   Al Raddadi, Rajaa ^s   Ragab, Ahmed ^t   Balkhy, Hanan H ^a,u   Balkhy, Abdulrahman ^p   Deeb, Ahmad M ^v   Al Mutairi, Hanan ^v   Al Dawood, Abdulaziz ^a   Merson, Laura ^w   Hayden, Frederick G ^w,x   Fowler, Robert A ^e,y,z   more..

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^c KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^d Aziz University   (Saudi Arabia)

^e Department of Biostatistics and Bioinformatics ^*  (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g ALFAISAL UNIVERSITY   (Saudi Arabia)

^h Dr Sulaiman Al Habib Group Hospitals ^*  (Saudi Arabia)

ⁱ IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^j King Fahad Medical City ^*  (Saudi Arabia)

^k KING FAHAD MEDICAL CITY   (Saudi Arabia)

^l AL NOOR SPECIALIST HOSPITAL   (Saudi Arabia)

^m KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

ⁿ KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^o KING SAUD UNIVERSITY   (Saudi Arabia)

^p TANTA UNIVERSITY HOSPITAL   (Egypt)

^q King Faisal Specialist Hospital and Research Center ^*  (Saudi Arabia)

^r King Abdul Aziz Hospital   (Saudi Arabia)

^s MINISTRY OF HEALTH   (Saudi Arabia)

^t KING FAHAD GENERAL HOSPITAL   (Saudi Arabia)

^u KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^v KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^w UNIVERSITY OF OXFORD   (United Kingdom)

^x UNIVERSITY OF VIRGINIA   (United States)

^y UNIVERSITY OF TORONTO   (Canada)

^z SUNNYBROOK RESEARCH INSTITUTE   (Canada)

more..

Author keywords

Coronavirus; Corticosteroid; Pneumonia; Respiratory distress syndrome; Saudi Arabia

Indexed keywords

HYDROCORTISONE; METHYLPREDNISOLONE; VIRUS RNA; CORTICOSTEROID;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; FEMALE; HOSPITAL MORTALITY; HUMAN; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY RATE; PRIORITY JOURNAL; SAUDI ARABIA; VIRAL CLEARANCE; CLINICAL TRIAL; CORONAVIRUS INFECTION; CRITICAL ILLNESS; INTENSIVE CARE; MULTICENTER STUDY; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; COHORT STUDIES; CORONAVIRUS INFECTIONS; CRITICAL CARE; CRITICAL ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SAUDI ARABIA; TREATMENT OUTCOME;

EID: 85045205939     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201706-1172OC     Document Type: Article

References (29)

1. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV). 2017 [accessed 2017 Apr 17]. Available from: http://www.who.int/emergencies/mers-cov/en/.
2. Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, et al. Middle East respiratory syndrome. N Engl J Med 2017;376: 584-594.
3. Arabi YM, Al-Omari A, Mandourah Y, Al-Hameed F, Sindi AA, Alraddadi B, et al.; Saudi Critical Care Trial Group. Critically ill patients with the Middle East respiratory syndrome: a multicenter retrospective cohort study. Crit Care Med 2017;45:1683-1695.
4. Yam LY, Lau AC, Lai FY, Shung E, Chan J, Wong V; Hong Kong Hospital Authority SARS Collaborative Group (HASCOG). Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong. J Infect 2007;54:28-39.
5. Auyeung TW, Lee JS, Lai WK, Choi CH, Lee HK, Lee JS, et al. The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study. J Infect 2005;51: 98-102.
6. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006;3:e343.
7. Lee N, Allen Chan KC, Hui DS, Ng EK, Wu A, Chiu RW, et al. Effects of early corticosteroid treatment on plasma SARS-associated coronavirus RNA concentrations in adult patients. J Clin Virol 2004;31: 304-309.
8. Lee N, Leo YS, Cao B, Chan PK, Kyaw WM, Uyeki TM, et al. Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. Eur Respir J 2015;45:1642-1652.
9. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam JS, Lim WS. Effect of corticosteroid therapy on influenza-related mortality: a systematic review and meta-analysis. J Infect Dis 2015;212:183-194.
10. Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, et al.; Canadian Critical Care Trials Group H1N1 Collaborative. The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Crit Care 2016;20:75.
11. Shintani AK, Girard TD, Eden SK, Arbogast PG, Moons KG, Ely EW. Immortal time bias in critical care research: application of timevarying Cox regression for observational cohort studies. Crit Care Med 2009;37:2939-2945.
12. Sjoding MW, Luo K, Miller MA, Iwashyna TJ. When do confounding by indication and inadequate risk adjustment bias critical care studies? A simulation study. Crit Care 2015;19:195.
13. Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003;168:49-53.
14. Arabi YM, Mandourah Y, Al-Hameed F, Al Omari A, Sindi A, Alraddadi B, et al. The association of corticosteroid therapy and the outcome of critically ill patients with the Middle East respiratory syndrome [abstract]. Am J Respir Crit Care Med 2017;195:A6868.
15. The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) [accessed 2017 Nov 15]. Available from: https://isaric.tghn.org/.
16. Vincent JL, de Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26: 1793-1800.
17. Hernań MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000;11:561-570.
18. Faries DE, Kadziola ZA. Analysis of longitudinal observational data using marginal structural models. In: Faries DE, Leon AC, Haro JM, Obenchain RL, editors. Analysis of observational health care data using SAS. Cary, NC: SAS Institute; 2010. pp. 211-230.
19. Robins JM, Hernań MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000;11: 550-560.
20. Cao B, Gao H, Zhou B, Deng X, Hu C, Deng C, et al. Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia. Crit Care Med 2016;44:e318-e328.
21. Rochwerg B, Oczkowski S, Siemieniuk RA, Menon K, Szczeklik W, English S, et al. Corticosteroids in sepsis: an updated systematic review and meta-analysis (protocol). BMJ Open 2017;7:e016847.
22. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, et al.; Korean Society of Critical Care Medicine H1N1 Collaborative. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011;183:1207-1214.
23. Brun-Buisson C, Richard JC, Mercat A, Thiébaut AC, Brochard L; REVA-SRLF A/H1N1v 2009 Registry Group. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011;183:1200-1206.
24. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, et al.; ESICM H1N1 Registry Contributors. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011;37:272-283.
25. The World Health Orgnization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. Interim guidance [updated 2015, July 2; accessed 2017 Sept 6]. Available from: http://www.who.int/csr/disease/coronavirus-infections/casemanagement- ipc/en/.
26. Torres A, Sibila O, Ferrer M, Polverino E, Menendez R, Mensa J, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA 2015;313: 677-686.
27. Blum CA, Nigro N, Briel M, Schuetz P, Ullmer E, Suter-Widmer I, et al. Adjunct prednisone therapy for patients with communityacquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2015;385:1511-1518.
28. Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med 2010;181:975-982.
29. Ruan SY, Lin HH, Huang CT, Kuo PH, Wu HD, Yu CJ. Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care 2014;18:R63.